Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2003
10/29/2003EP0984788B1 Pharmaceutical compositions of peptides having low solubility in physiological medium
10/29/2003EP0951553B1 Adenovirus e4 proteins for inducing cell death
10/29/2003EP0946736B1 Method for expression of heterologous proteins in yeast
10/29/2003EP0941122B1 Compositions for polynucleotide delivery
10/29/2003EP0920501B1 Neuritin, a neurogene
10/29/2003EP0915911B1 Parathyroid hormone analogues for the treatment of osteoporosis
10/29/2003EP0835129B1 Prevention of a disease having the characteristics of diabetes
10/29/2003EP0703985B1 Recombinant stratum corneum chymotryptic enzyme (scce)
10/29/2003EP0627000B1 Mammalian expression systems for hcv proteins
10/29/2003EP0594803B1 Composition for reducing side-effects of a drug
10/29/2003EP0444186B2 Pharmaceutical composition that makes cells expressing mhc class ii antigens targets for cytotoxic t-cells
10/29/2003EP0293394B2 Novel thrombolytic proteins
10/29/2003CN1452634A HLA binding peptides and their uses
10/29/2003CN1452633A Mammalian genes, related reagent and methods
10/29/2003CN1452632A Extended native chemical ligation
10/29/2003CN1452494A Use of secretin-receptorl igands in treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD)
10/29/2003CN1452493A Method for cell adhesion and wound healing
10/29/2003CN1452492A Neuroprotective peptides
10/29/2003CN1451747A Medusa cystatin gene, and expression and use thereof
10/29/2003CN1451745A Natto kinase produced using Bacillus subtilis, and producing method and use thereof
10/29/2003CN1451666A Recombinant fusion resisting tomur attack and transfer
10/29/2003CN1451656A Novel salt of perindopril and pharmaceutical composition contg. same
10/29/2003CN1451436A Use of lysozyme and relative pure deriv. or raw liquid for preventing and treating diseases in sea and frech-water breeding
10/29/2003CN1451435A Medicine for treating phenylketouria, and preparing process and use thereof
10/29/2003CN1451389A Agent for promoting cell activation for external use
10/29/2003CN1451372A Method for preparing medicine targeted liposome
10/29/2003CN1125877C Hepatitis G. Virus and molecular cloning thereof
10/29/2003CN1125650C Human immunization strengthening medicine
10/28/2003US6639060 DNA segment encoding a receptor protein related to the erbB proto-oncogene family which previously has not been known; tool for screening for anticancer agents
10/28/2003US6639058 Dissolving amyloid plaque
10/28/2003US6639055 Method for making humanized antibodies
10/28/2003US6639052 Human ADA2 polypeptides
10/28/2003US6639051 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
10/28/2003US6639050 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
10/28/2003US6639014 Multiblock biodegradable hydrogels for drug delivery and tissue treatment
10/28/2003US6638949 Angiogenesis inhibitor is selective, such as a fumagillol derivative like 0-chloroacetylcarbamoyl-Fumagillol, thalidomide, or a selective drug having more than one activity, such as minocycline or penicilliamine which also
10/28/2003US6638941 Conformationallly constrained peptidomimetics as β-turn templates and modulators of SH3 domains
10/28/2003US6638913 Concentrated injection and infusion solution for intravenous administration
10/28/2003US6638912 Peptide compositions mimicking TGF-β activity
10/28/2003US6638911 Modulating agents comprise one or more of a peptide sequence that is at least 50% identical to a desmosomal cadherin CAR sequence; a non-peptide mimetic of a desmosomal cadherin CAR sequence; a substance, such as an antibody or antigen binding
10/28/2003US6638910 Compositions and methods for controlling plant pests
10/28/2003US6638909 Wound healing compositions containing alpha-1-antitrypsin
10/28/2003US6638907 Laminin 8 and methods for its use
10/28/2003US6638906 Amphiphilic polymers and polypeptide conjugates comprising same
10/28/2003US6638905 G protein-coupled corticotropin-releasing factor; for use in treatment of endocrine, gastrointestinal, reproductive, central nervous and immune disorders
10/28/2003US6638771 Uses an immune reaction to detect soluble liver antigen ("SLA") auto-antibodies
10/28/2003US6638768 Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made
10/28/2003US6638764 Modulating the interaction of immune complexes with tissue Fc receptors by introducing an inhibitor of an endogenous kinase
10/28/2003US6638762 Tissue-vectors specific replication and gene expression
10/28/2003US6638756 Chimeric cell-targeting pathogenic organism and method of therapeutic use
10/28/2003US6638750 Diagnosing angiogenesis-related diseases; molecular hybridization, genetic engineering
10/28/2003US6638745 Antiinflammatory agents, anticarcinogenic agents; arteriosclerosis, psoriasis; gene therapy, diagnosis; genetic engineering
10/28/2003US6638741 Differentiation-suppressive polypeptide serrate-2
10/28/2003US6638736 Gene expression inhibition; cancer and neurodegenerative disease diagnosis; molecular hybridization
10/28/2003US6638727 Intraductally administering an estrogen activity modulator
10/28/2003US6638724 BLNK proteins
10/28/2003US6638721 Human protein kinases and uses therefor
10/28/2003US6638540 Plant extracts for the treatment of increased bone resorption
10/28/2003US6638531 Peptide antibiotics for resistant bacteria; fungicides
10/28/2003US6638522 Carrier comprising solubilizing amount of propylene glycol monoester of C6-C18 fatty acid and nonionic surfactant
10/28/2003US6638518 Administering microbial or Mycobacterial polypeptide as antiasthmatic agent
10/28/2003US6638517 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
10/28/2003US6638515 Method of blocking cytotoxic activity in patients with amyotrophic lateral sclerosis using protein V
10/28/2003US6638512 Method for treating subjects by using BAGE tumor rejection antigen precursors or tumor rejection antigens
10/28/2003US6638506 Detecting for mononucleic cells
10/28/2003US6638505 For prevention of influenza virus binding to cells, therapy of schizophrenia and diagnosing chronic viral disease associated with development of cancer
10/28/2003US6638504 Methods for treating cancer
10/28/2003US6638503 Extraction of actinokinase
10/28/2003US6638502 Comprising nucleic acid sequence encoding an amino terminal fragment of urokinase that comprises and epidermal growth factor-like domain; gene expression control; antimetastasis agents
10/28/2003US6638500 Polyol-IFN-βconjugates modified at Cys-17 and composition containing same
10/28/2003CA2283939C Non-antigenic branched polymer conjugates
10/28/2003CA2118010C Antibodies specific for carcinoma-associated antigens
10/28/2003CA2101179C Phenylimidazolidine derivatives, their preparation and their use
10/28/2003CA2058020C Short peptides with insulin activity
10/23/2003WO2003088650A1 Digital camera
10/23/2003WO2003087843A2 Diagnostics and therapeutics for diseases associated with mas related gene f (mrgf)
10/23/2003WO2003087840A2 Protein involved in cancer
10/23/2003WO2003087832A2 Diagnosis of carcinoma using raigi polypeptides
10/23/2003WO2003087818A2 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signaltransduction
10/23/2003WO2003087762A2 Methyl-cpg binding domain protein 2 homologs
10/23/2003WO2003087411A1 Method to inhibit cell growth using oligonucleotides
10/23/2003WO2003087408A2 Schizophrenia associated genes
10/23/2003WO2003087406A1 Diagnostic and therapeutic use of an atp-binding cassette gene and protein for neurodegenerative diseases
10/23/2003WO2003087383A1 Compositions for delivering enyzmes involved in amino acid metabolism using recombinant ademo-associated virus virons (raav virons), and method and use for treating aminoi acid metabolic disorders using such raav virons
10/23/2003WO2003087380A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use
10/23/2003WO2003087375A1 Cartilage differentiation regulating gene
10/23/2003WO2003087374A1 Derivatives of the il-2 receptor gamma chain, their production and use.
10/23/2003WO2003087373A2 Production of recombinant fragments of muscle acetylcholine receptor and their use for ex vivo immunoadsorption of anti-ach receptor antibodies from myasthenic patients
10/23/2003WO2003087369A2 Ribozyme capable of specifically cleaving mmp-13
10/23/2003WO2003087368A2 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification
10/23/2003WO2003087367A2 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
10/23/2003WO2003087362A1 Novel g protein-coupled receptor gene and protein bg8
10/23/2003WO2003087355A1 Inactivation resistant factor viii
10/23/2003WO2003087345A2 Stimulation of nerve cell regeneration
10/23/2003WO2003087338A2 Her-2 receptor tyrosine kinase molecules and uses thereof
10/23/2003WO2003087331A2 Polyvalent cation-sensing receptor in atlantic salmon
10/23/2003WO2003087325A2 Methods and compositions for preventing and treating microbial infections
10/23/2003WO2003087320A2 Antagonists of il-21 and modulation of il-21-mediated t cell responses
10/23/2003WO2003087319A2 Carcinoembryonic antigen cell adhesion molecule 1 (ceacam1) structure and uses thereof in drug identification and screening
10/23/2003WO2003087318A2 Truncated 24 kda basic fibroblast growth factor
1 ... 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 1754 1755 1756 1757 1758 1759 1760 1761 1762 1763 1764 ... 3163